TRCT
ETRM

Tower Research Capital (TRC)’s EnteroMedics Inc. ETRM Stock Holding History

Tower Research Capital (TRC)’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1
Closed -$1K – 5797
2015
Q1 		$1K Buy
+1
New +$1.21K ﹤0.01% 4344
2014
Q4 		– Sell
-3
Closed -$4K – 5624
2014
Q3 		$4K Sell
3
-1
-25% -$1.47K ﹤0.01% 3567
2014
Q2 		$6K Sell
4
-3
-43% -$5.61K ﹤0.01% 2821
2014
Q1 		$13K Buy
+7
New +$16.6K ﹤0.01% 2400
2013
Q4 		– Hold
0
– -$1K – 5589
2013
Q3 		– Hold
0
– – – 4510

Other funds holding ETRM

TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
B
Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return

Tower Research Capital (TRC)'s ETRM Position: Q2 2015 in Review

Tower Research Capital (TRC) sold out of EnteroMedics Inc. (ETRM) in Q2 2015, closing a stake of 1 share — an estimated $1K sold.

Tower Research Capital (TRC) first reported a position in ETRM in Q1 2014 and held it in 4 quarters. The position peaked at $13K in Q1 2014. 46 funds tracked by Wall St. Rank hold ETRM as of Q2 2015.

  • Tower Research Capital (TRC) reported no remaining EnteroMedics Inc. position as of Q2 2015 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1 EnteroMedics Inc. share in Q2 2015, an estimated $1K.
  • Tower Research Capital (TRC) first reported a position in EnteroMedics Inc. in Q1 2014 and held it in 4 quarters.
  • Tower Research Capital (TRC)'s EnteroMedics Inc. position peaked at $13K in Q1 2014.
  • 46 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q2 2015.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2015, filed 30 Jul 2015.